Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 1

Status

Recruiting 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 49Gastrointestinal 43Genitourinary 41Gynecologic 27Other 24Head & Neck 21Thoracic 20CNS 15Other hematologic neoplasm 11Lymphoid 11Dermatologic 8Tumor-Agnostic 7Sarcoma 6Other solid neoplasm 5Plasma cell 3Endocrine 3NET 2Classical hematology 2Other neoplasm 1

Conditions

TP53 Y220C Mutation 1Solid Tumor, Adult 1Prostate Cancer Recurrent 1Advanced Solid Tumor 1Advanced Pancreatic Cancer 1

Interventions

Cisplatin 145pembrolizumab 129Carboplatin 125Injections 108Pemetrexed 97Paclitaxel 97Gemcitabine 85Irinotecan 75Nivolumab 71Cyclophosphamide 71Docetaxel 68Bevacizumab 57Oxaliplatin 49Fluorouracil 48atezolizumab 46Capecitabine 46Etoposide 42Leucovorin 41tislelizumab 40toripalimab 36fludarabine 32Ipilimumab 30Drug Therapy 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26Specimen Handling 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Metformin × Other solid neoplasm × Clear all
NCT05036226 2026-05-13

COAST

Medical University of South Carolina

Phase 1/2 Recruiting
76 enrolled
GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

NCT07372625 2026-03-12

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

PMV Pharmaceuticals, Inc

Phase 1 Recruiting
14 enrolled
Other solid neoplasm

TP53 Y220C Mutation

NCT07098299 2025-11-06

Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies

Barbara Ann Karmanos Cancer Institute

Phase 1 Recruiting
60 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT03889795 2025-10-20

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

University of Toledo

Phase 1 Active not recruiting
15 enrolled
GastrointestinalOther solid neoplasm

Advanced Pancreatic Cancer

NCT04428086 2022-07-26

A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects.

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
19 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡